Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF AUGUST 24, 2022 SAM #7572
SPECIAL NOTICE

99 -- TECHNOLOGY TRANSFER OPPORTUNITY: Carbon nanotube mesh bucky paper capsule (TOP2-195)

Notice Date
8/22/2022 12:29:04 PM
 
Notice Type
Special Notice
 
NAICS
927110 — Space Research and Technology
 
Contracting Office
NASA HEADQUARTERS WASHINGTON DC 20546 USA
 
ZIP Code
20546
 
Solicitation Number
T2P-ARC-000113
 
Response Due
8/22/2023 2:00:00 PM
 
Point of Contact
NASA�s Technology Transfer Program
 
E-Mail Address
Agency-Patent-Licensing@mail.nasa.gov
(Agency-Patent-Licensing@mail.nasa.gov)
 
Description
NASA�s Technology Transfer Program solicits inquiries from companies interested in obtaining license rights to commercialize, manufacture and market the following technology. License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use. NASA provides no funding in conjunction with these potential licenses. THE TECHNOLOGY: NASA has developed an innovative method for fabricating containers (biocapsules) made of biocompatible mesh for holding living cells and tissues, to facilitate transplantation into the body, for a wide range of high-impact medical applications. The biocompatible mesh (buckypaper) is made of carbon nanotubes (CNTs), and the containers are fabricated by depositing the nanotubes onto pre-formed molds, in order to achieve the desired shape and size of the biocapsule. Various forms are possible, including hollow tubes, closed cylinders, and more complex shapes, determined by the configuration of the mold. The biocompatibility of the capsule makes it possible to implant a variety of cells into a host, even cells that would otherwise be considered foreign, such as cells from unmatched donors, specially engineered cells, and even non-human cells. Because the capsule pores are too small for the cells to pass through, the cells stay inside the capsule, where they are protected from the host immune system. To express interest in this opportunity, please submit a license application through NASA�s Automated Technology Licensing Application System (ATLAS) by visiting https://technology.nasa.gov/patent/TOP2-195 If you have any questions, please e-mail NASA�s Technology Transfer Program at Agency-Patent-Licensing@mail.nasa.gov with the title of this Technology Transfer Opportunity as listed in this SAM.gov notice and your preferred contact information. For more information about licensing other NASA-developed technologies, please visit the NASA Technology Transfer Portal at https://technology.nasa.gov/ These responses are provided to members of NASA�s Technology Transfer Program for the purpose of promoting public awareness of NASA-developed technology products, and conducting preliminary market research to determine public interest in and potential for future licensing opportunities. No follow-on procurement is expected to result from responses to this Notice.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/8341918f52bd427a8fc3adf6c5edd14b/view)
 
Record
SN06435648-F 20220824/220823060732 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.